← Back to Search

Dietary Supplement

Daily Balance Gummy for Perimenopause and Menopause

N/A

Waitlist Available

Research Sponsored by Hologram Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial will investigate if daily supplements can reduce symptoms of perimenopause and menopause, such as hot flashes, fatigue, and brain fog.

Eligible Conditions

Menopause
Perimenopause

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in brain fog. [Baseline to Week 12]

Change in fatigue. [Baseline to Week 12]

Change in hot flashes. [Baseline to Week 12]

+4 more

Secondary outcome measures

Changes in participant-reported quality of life. [Baseline to Week 12]

Trial Design

1Treatment groups

Experimental Treatment

Group I: Daily Balance GummyExperimental Treatment1 Intervention

One Daily Balance Gummy should be taken with the last meal of the day.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Daily Balance Gummy

2023

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Hologram SciencesLead Sponsor

CitruslabsIndustry Sponsor

68 Previous Clinical Trials

3,805 Total Patients Enrolled

2 Trials studying Menopause

142 Patients Enrolled for Menopause

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research accommodate participants aged seventy-five and above?

"This research is enrolling participants between 40 and 65 years of age."

Answered by AI

Can I become a participant in this experimentation?

"Qualified applicants for this research must be in the menopausal stage of life and between 40 to 65 years old. There is an estimated need for around forty participants."

Answered by AI

Are there opportunities for additional participants in this research project?

"According to the clinicaltrials.gov database, this trial is not enlisting participants at present; it was initially posted on August 14th 2023 and most recently altered on August 30th 2023. However, there are 40 other medical studies currently recruiting patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Study to Examine the Effects of a Daily Supplement on Common Symptoms of Perimenopause and Menopause

2023. "A Study to Examine the Effects of a Daily Supplement on Common Symptoms of Perimenopause and Menopause". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06018740.